T2B’s AI in Biopharma Communications Survey Is Now Live
|
Hi! We’ve generally been pretty cautious about broad community surveys at T2B, but anecdotal feedback around AI could only get us so far. This felt like a situation where broader input is genuinely worth it. AI is an area where our field would benefit from a clearer benchmark across roles and work settings. Yes, there are already surveys out there on AI in healthcare, as well as in marketing and comms more broadly, and those are useful in their own right. But what we haven’t really had is something that reflects the realities of life sciences comms and the specific tensions many of us are navigating around tools, policy, disclosure, training, resourcing, and expectations for the role itself. So, today, we’re opening T2B’s inaugural AI in Biopharma Communications Survey, developed through our AI Roundtable with Knowledge Partner Syneos Health Communications. AI survey goals:We want to better understand how AI is actually showing up across workflows, teams, and roles, from early experimentation to deeper integration. We’re also looking at where formal policy and day-to-day behavior diverge, and what the findings may reveal about how the biopharma communicator’s role is evolving across in-house teams, agencies, and independent consultants. My hope is that this gives our corner of the industry a more concrete benchmark to work from… Two key purposes of this baseline:
Share how you use and what you think about AI:If you work in life sciences communications, we’d really value your perspective. The survey is open through May 18th (so, if you’re in the middle of earnings, please bookmark this and come back to it later). It should take about 10 minutes to complete, and you do not need to be a T2B member to participate.
We’ll share the first public look at the findings at the Biopharma Comms Forum in Boston on June 11th. Thank you for helping us define the benchmark of how AI is being used in our day-to-day, and importantly, how our role is evolving because of it. Have a good weekend! Lynnea P.S. - Speaking of the T2B Forum, Clarity at the Flashpoint – registration is now open. Sign up here! |
T2B Monthly
Hi! If your purview includes investor relations, I invite you to consider applying to join Year 2 of T2B’s IR Roundtable. Apply here by midnight for one of three open spots on this roundtable. What is the IR Roundtable? Chaired by Deborah Elson, who heads up Corporate Communications and IR at Tonix Pharmaceuticals, this group brings biopharma communicators together to advance how IR and corporate communications work together to shape positioning and credibility. In Year 2, the group will...
Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...
Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...